A population‐based study of palliative rectal cancer patients with an unremoved primary tumour: Symptoms, complications and management
Colorectal Disease · 2025
DOI: 10.1111/codi.70104 ↗Kurz gefasst
Fachartikel in der Zeitschrift Colorectal Disease, 2025. Verfasst von Gustav Kejving und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden. Hauptthemen laut MEDLINE: Rectal Neoplasms, Palliative Care, Postoperative Complications. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish cancer society and Region Västerbotten.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Aim
Palliative rectal cancer patients typically retain their primary tumour, as trials have concluded no survival benefit of tumour resection in non‐curative patients. This patient group is understudied regarding the natural course of the remaining tumour, particularly concerning the need of surgical management.
Method
This was a retrospective study on rectal cancer patients diagnosed between 2007 and 2020 in Region Västerbotten, Sweden. Data were obtained from the Swedish Colorectal Cancer Registry and chart review. Patients were excluded if treated with curative intent, underwent primary tumour resection, had a synchronous colorectal cancer, had locally recurrent colorectal cancer, or refused treatment. Patients were followed from diagnosis until death or end of follow‐up. Indications for palliative treatment, tumour‐related complications and surgical and oncological management were investigated, with a stratified analysis for study period and patient age.
Results
Some 156 patients remained after applying exclusion criteria. The majority had metastasized and incurable disease (76%). Almost half suffered local complications (44%) and 48% underwent surgical intervention, due to the unremoved primary tumour. Tumour perforation occurred in 7% with a significantly higher risk in patients aged ≤75 years ( p = 0.009). Bowel obstruction afflicted 23%, while 40% underwent stoma diversion. Almost half received chemotherapy (48%) and radiotherapy (42%), respectively.
Conclusion
Rectal cancer patients with an unremoved primary tumour face a substantial risk of local complications, often necessitating surgical intervention. Therefore, the benefits of surgical resection should be carefully considered, especially for patients with a longer estimated survival. Further research is needed to accurately identify patients where tumour removal might be beneficial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Diagnostics and Intervention, Surgery, Umeå University, Umeå, Sweden.
- Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden.
ORCID-Profile: Gustav Kejving
Förderung
- Swedish cancer society and Region Västerbotten
Zitieren
APA
Kejving, G., Sandén, G., Ljuslinder, I., Rutegård, J., Vinnars, P., & Rutegård, M. (2025). A population‐based study of palliative rectal cancer patients with an unremoved primary tumour: Symptoms, complications and management. Colorectal Disease. https://doi.org/10.1111/codi.70104
Vancouver
Kejving G, Sandén G, Ljuslinder I, Rutegård J, Vinnars P, Rutegård M. A population‐based study of palliative rectal cancer patients with an unremoved primary tumour: Symptoms, complications and management. Colorectal Disease. 2025. doi:10.1111/codi.70104
BibTeX
@article{Kejving2025,
author = {Kejving, Gustav and Sandén, Gustav and Ljuslinder, Ingrid and Rutegård, Jörgen and Vinnars, Petrus and Rutegård, Martin},
title = {A population‐based study of palliative rectal cancer patients with an unremoved primary tumour: Symptoms, complications and management},
journal = {Colorectal Disease},
year = {2025},
doi = {10.1111/codi.70104}
}
EUVIMED